2 min read
First Retrospective Crohn’s/CurQD® Study: Success!
Aug 8, 2025 - Summer Pitocchelli-Schwartzman
We speak about IBD as a generalized group, but in reality there are at least two distinct subtypes: Ulcerative Colitis and Crohn’s Disease. While other subtypes exist, these two are the main categories under which most patients fall, with Ulcerative Colitis primarily impacting the large intestine and the rectum, while Crohn’s Disease can impact anywhere […]
Read more
4 min read
Live Q&A: Experts Discuss Natural, Evidence-Based CurQD for IBD Support
Jul 22, 2025- Evinature
Read more
4 min read
Live Q&A: Experts Discuss Natural, Evidence-Based CurQD for IBD Support
Jul 22, 2025- Evinature
Read more
3 min read
Evinature Co-Founder Nir Salomon, ChB, Sheds Light on CurQD Protocol in Live Interview with Aaron Blocker
Jun 29, 2025 - Evinature
Evinature co-founder Nir Salomon, ChB, joined IBD advocate Aaron Blocker in a live Instagram interview to discuss the science, personalization, and clinical success of the CurQD Protocol as a rigorous, physician-supported nutraceutical treatment for IBD.
Read more
3 min read
Steve’s Story: Finding Support After Years of Trial and Error
Jun 26, 2025- jonathan
Read more
2 min read
Jason’s Story: Harsh 1st Year with Crohn’s and His Road Forward
Jun 18, 2025- Evinature
Read more
2 min read
Evinature’s CurQD Protocol Presented at SickKids Hospital, Toronto
Jun 5, 2025- Evinature
Read more
